Cantaloupe, Inc.

CTLP

CIK 0000896429 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$79M
↑+6.8% +$5Mvs FY2024 (Q4)
Operating Income
$2M
↓-73.9% -$5Mvs FY2024 (Q4)
Gross Profit
$31M
↓-0.6% -$176Kvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
49/100
  • Profitability
    19ROIC 8.8% (10% = solid, 20%+ = moat)
  • Liquidity
    68Current Ratio 1.86 (above 1.5 = solid)
  • Leverage
    92D/E 0.15 (under 0.5 = conservative)
  • Efficiency
    49Asset Turnover 0.84x (1.0+ = capital-efficient)
  • Growth
    39Revenue YoY +6.8% (10% = solid, 25%+ = elite)
  • Margin Trend
    25Op Margin 2.0% · trend -1.5pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project CTLP's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

8%

Trailing CAGR unavailable; default 8%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$0.77
Total enterprise IV
$57M
Diluted shares
0.07B
Terminal PV
$42M (72% of total)
Year-5 FCF
$5M
YearProjected FCFDiscounted PV
+1$4M$3M
+2$4M$3M
+3$4M$3M
+4$5M$3M
+5$5M$3M
Terminal$67M$42M

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$16M
investment in PP&E
Stock buybacks (TTM)
share count reduction
Stock-based comp (TTM)
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$382M
everything owned
Total liabilities
$127M
everything owed
Stockholders' equity
$252M
shareholder claim
Net debt
$-15M
Net cash position ($15M)

Recent performance · 62 quarters

Revenue↑+6.8% +$5M
$79M
Net Income↓-101.4% -$5M
$-70K
Free Cash Flow↑+83.7% +$3M
$-614K
Operating Margin↓-6.3pts
2.0%

Drill down